Abstract
All in-vivo medical imaging is impacted by patient motion, especially respiratory motion, which has a significant influence on clinical workflows in diagnostic imaging and radiation therapy. Many technologies such as motion artifact reduction and tumor tracking algorithms have been developed to compensate for respiratory motion during imaging. To assess these technologies, respiratory motion phantoms (RMPs) are required as preclinical testing environments, for instance, in computed tomography (CT). However, current RMPs are highly simplified and do not exhibit realistic tissue structures or deformation patterns. With the rise of more complex motion compensation technologies such as deep learning-based algorithms, there is a need for more realistic RMPs. This work introduces PixelPrint4D, a 3D printing method designed to fabricate lifelike, patient-specific deformable lung phantoms for CT imaging. The phantom demonstrated accurate replication of patient lung structures, textures, and attenuation profiles. Furthermore, it exhibited accurate nonrigid deformations, volume changes, and attenuation changes under compression. PixelPrint4D enables the production of highly realistic RMPs, surpassing existing models to offer more robust testing environments for a diverse array of novel CT technologies.
Competing Interest Statement
AP is an employee of Philips Healthcare. The other authors have no relevant conflicts of interest to disclose.
Funding Statement
This study was funded by the National Institutes of Health (R01EB035092, R01EB030494, & R01EB031592) and Philips Healthcare.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of the University of Pennsylvania gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
